• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy".

作者信息

Yang Haitang, Hall Sean R R, Sun Beibei, Yao Feng

机构信息

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, 200030, Shanghai, People's Republic of China.

Gillies McIndoe Research Institute, Wellington, 6021, New Zealand.

出版信息

Br J Cancer. 2021 Mar;124(6):1177-1178. doi: 10.1038/s41416-020-01214-8. Epub 2020 Dec 18.

DOI:10.1038/s41416-020-01214-8
PMID:33339893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961042/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a404/7961042/19cc18fac630/41416_2020_1214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a404/7961042/19cc18fac630/41416_2020_1214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a404/7961042/19cc18fac630/41416_2020_1214_Fig1_HTML.jpg

相似文献

1
Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy".关于“恶性腹膜间皮瘤中PD-L1表达的异质性与全身或腹腔内化疗”的评论
Br J Cancer. 2021 Mar;124(6):1177-1178. doi: 10.1038/s41416-020-01214-8. Epub 2020 Dec 18.
2
Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy".对关于“恶性腹膜间皮瘤全身或腹腔内化疗后PD-L1表达的异质性”评论的回应
Br J Cancer. 2021 Mar;124(6):1179-1180. doi: 10.1038/s41416-020-01215-7. Epub 2020 Dec 14.
3
Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy.恶性腹膜间皮瘤患者接受全身或腹腔化疗时 PD-L1 表达的异质性。
Br J Cancer. 2021 Feb;124(3):564-566. doi: 10.1038/s41416-020-01130-x. Epub 2020 Oct 26.
4
Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.达科 PD-L1 22C3 pharmDx 和达科 PD-L1 28-8 pharmDx 检测试剂盒评估恶性胸膜和腹膜间皮瘤的肿瘤 PD-L1 表达。
Hum Pathol. 2019 May;87:11-17. doi: 10.1016/j.humpath.2019.02.001. Epub 2019 Feb 20.
5
Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study.恶性腹膜间皮瘤患者 PD-L1 的表达：一项初步研究。
J Surg Res. 2022 Sep;277:131-137. doi: 10.1016/j.jss.2022.04.005. Epub 2022 Apr 27.
6
Malignant Mesothelioma Effusions Are Infiltrated by CD3 T Cells Highly Expressing PD-L1 and the PD-L1 Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab.恶性间皮瘤积液被高表达PD-L1的CD3 T细胞浸润，且这些积液中的PD-L1肿瘤细胞对抗PD-L1抗体阿维鲁单抗介导的ADCC敏感。
J Thorac Oncol. 2016 Nov;11(11):1993-2005. doi: 10.1016/j.jtho.2016.07.033. Epub 2016 Aug 17.
7
Expression status of PD-L1 and B7-H3 in mesothelioma.间皮瘤中程序性死亡受体配体1（PD-L1）和B7-H3的表达状态
Pathol Int. 2020 Dec;70(12):999-1008. doi: 10.1111/pin.13028. Epub 2020 Oct 7.
8
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement.抗 PD-1 治疗在高克隆 PD-L1 表达和 EML4-ALK 重排的上皮样间皮瘤中产生显著临床应答。
Lung Cancer. 2020 Apr;142:47-50. doi: 10.1016/j.lungcan.2020.02.006. Epub 2020 Feb 14.
9
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.恶性胸膜间皮瘤免疫微环境和检查点表达：与临床病理特征及随时间推移的肿瘤内异质性的相关性。
Ann Oncol. 2018 May 1;29(5):1258-1265. doi: 10.1093/annonc/mdy086.
10
Prognostic Role of PD-L1 in Malignant Pleural Mesothelioma: Unraveling the Complexity of the Tumor Microenvironment in Mesothelioma.
Ann Thorac Surg. 2021 Nov;112(5):1583-1584. doi: 10.1016/j.athoracsur.2020.12.052. Epub 2021 Jan 29.

引用本文的文献

1
Dihydroartemisinin ameliorates chronic nonbacterial prostatitis and epithelial cellular inflammation by blocking the E2F7/HIF1α pathway.双氢青蒿素通过阻断 E2F7/HIF1α 通路改善慢性非细菌性前列腺炎和上皮细胞炎症。
Inflamm Res. 2022 Apr;71(4):449-460. doi: 10.1007/s00011-022-01544-8. Epub 2022 Mar 13.
2
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.NF2与经典的Hippo-YAP信号通路界定了人类胸膜间皮瘤中不同的肿瘤亚群，这些亚群具有不同的免疫缺陷特征及治疗意义。
Cancers (Basel). 2021 Mar 29;13(7):1561. doi: 10.3390/cancers13071561.
3
Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.
恶性胸膜间皮瘤的生物标志物——关于炎症的新观点
Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658.